O. V. Kel

587 citations
6 papers · 491 indexed · h-index 5
Topics
Genomics and Chromatin Dynamics (5 papers)RNA Research and Splicing (3 papers)RNA and protein synthesis mechanisms (3 papers)
Journals
Nucleic Acids ResearchPubMed
Partner nations
RussiaGermanyChina

In The Last Decade

O. V. Kel

5 papers receiving 473 citations

Peers

O. V. Kel
Comparison fields: 5 of 80
  • Molecular Biology 356
  • Genetics 76
  • Immunology 69
  • Oncology 52
  • Cancer Research 45
Replace Ines Liebich with:
Ines Liebich Germany
Frank Schacherer Germany
J. Guhaniyogi United States
Zenaida P. Lopez-Dee United States
Laure Twyffels Belgium
Arne Soete Belgium
James Bilakovics United States
Willard Lou United States
Olivier Marinx France
Melvyn Hollis United Kingdom
O. V. Kel relative to Ines Liebich Germany Ines Liebich's profile →
Citations per field
00.5×1.5×
Ines Liebich · 1×
Citations per year

Countries citing papers authored by O. V. Kel

Since Specialization
Citations

This map shows the geographic impact of O. V. Kel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. V. Kel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. V. Kel more than expected).

Fields of papers citing papers by O. V. Kel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. V. Kel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. V. Kel. The network helps show where O. V. Kel may publish in the future.

Co-authorship network of co-authors of O. V. Kel

This figure shows the co-authorship network connecting the top 25 collaborators of O. V. Kel. A scholar is included among the top collaborators of O. V. Kel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. V. Kel. O. V. Kel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
#WorkIndexed citations
1 0
2 278
3 124
4
[Intergenic interrelations in regulating the cell cycle: key role of E2F family transcription factors].
4
5 76
6
Computer tool FUNSITE for analysis of eukaryotic regulatory genomic sequences.
9

About O. V. Kel

O. V. Kel is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry, having authored 6 papers that have together received 491 indexed citations. Recurring topics across this work include Genomics and Chromatin Dynamics (5 papers), RNA Research and Splicing (3 papers) and RNA and protein synthesis mechanisms (3 papers). The work is most often cited by research in Molecular Biology (356 citations), Immunology (69 citations) and Cancer Research (45 citations). O. V. Kel has collaborated with scholars based in Russia, Germany and China. Frequent co-authors include Alexander Kel, Edgar Wingender, T. Heinemeyer, Holger Karas, Н. А. Колчанов, A. G. Romaschenko, Ines Liebich, Frank Schacherer, Peter Dietze and Luciano Milanesi. Their work appears in journals such as Nucleic Acids Research and PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026